Friederike Gieseking
- Obstetrics and Gynecology top 2%
- Endometrial and Cervical Cancer Treatments 6
- Epidemiology top 10%
- Cervical Cancer and HPV Research 9
- Dermatology top 10%
- Cancer and Skin Lesions 3
- Surgery top 10%
- Genital Health and Disease 5
- Colorectal and Anal Carcinomas 4
- Reproductive Medicine top 10%
-
- Cancer Cells and Metastasis 3
- Cancer Treatment and Pharmacology 2
-
- Cancer Genomics and Diagnostics 3
- Co-authors
- Linn WoelberSven� MahnerFritz JaenickeMatthias ChoschzickCordula PetersenJoerg SchwarzKarl Ulrich PetryChristine zu Eulenburg
- Journals
- Annals of Oncology (1 paper)Journal of the American Academy of Dermatology (1 paper)European Journal of Cancer (2 papers)
- Partner nations
- GermanyBelgiumSwitzerland
In The Last Decade
Friederike Gieseking
22 papers receiving 646 citations
Peers
Comparison fields: 5 of 60
- Obstetrics and Gynecology 253
- Epidemiology 452
- Dermatology 74
- Surgery 321
- Reproductive Medicine 51
Countries citing papers authored by Friederike Gieseking
This map shows the geographic impact of Friederike Gieseking's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Friederike Gieseking with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Friederike Gieseking more than expected).
Fields of papers citing papers by Friederike Gieseking
This network shows the impact of papers produced by Friederike Gieseking. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Friederike Gieseking. The network helps show where Friederike Gieseking may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Friederike Gieseking, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 44 | |
| 2 | 2015 | 3 | |
| 3 | 2015 | 14 | |
| 4 | 2014 | 47 | |
| 5 | 2014 | 3 | |
| 6 | 2014 | 22 | |
| 7 | 2012 | 63 | |
| 8 | 2012 | 11 | |
| 9 | 2012 | 79 | |
| 10 | 2011 | 73 | |
| 11 | 2011 | 55 | |
| 12 | 2009 | 20 | |
| 13 | 2008 | 4 | |
| 14 | 2008 | 80 | |
| 15 | 2001 | 5 | |
| 16 | 2001 | 13 | |
| 17 | 2001 | 15 | |
| 18 | 1999 | 12 | |
| 19 | High dose mitoxantrone with thiotepa, cyclophosphamide and autologous stem cell rescue for high risk stage II and stage III breast cancer. German GABG-4/EH-93-Study. | 1996 | 4 |
| 20 | 1995 | 2 |
About Friederike Gieseking
Friederike Gieseking is a scholar working on Obstetrics and Gynecology, Dermatology and Cancer Research, having authored 23 papers that have together received 656 indexed citations. Recurring topics across this work include Cervical Cancer and HPV Research (9 papers), Endometrial and Cervical Cancer Treatments (6 papers), Genital Health and Disease (5 papers), Colorectal and Anal Carcinomas (4 papers), Cancer and Skin Lesions (3 papers), Cancer Cells and Metastasis (3 papers), Cancer Genomics and Diagnostics (3 papers) and Cancer Treatment and Pharmacology (2 papers). The work is most often cited by research in Obstetrics and Gynecology (253 citations), Epidemiology (452 citations) and Dermatology (74 citations). Friederike Gieseking has collaborated with scholars based in Germany, Belgium and Switzerland. Frequent co-authors include Linn Woelber, Sven� Mahner, Fritz Jaenicke, Matthias Choschzick, Cordula Petersen, Joerg Schwarz, Karl Ulrich Petry, Christine zu Eulenburg, Stève Bénard and J. Gabrielle Breugelmans. Their work appears in journals such as Annals of Oncology, Journal of the American Academy of Dermatology and European Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.